Immune Checkpoint Receptors Tim-3 and PD-1 Regulate Monocyte and T Lymphocyte Function in Septic Patients

被引:38
|
作者
Xia, Qi [1 ]
Wei, Li [1 ]
Zhang, Yuntao [2 ]
Sheng, Jifang [1 ]
Wu, Wei [1 ]
Zhang, Yi [3 ,4 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 1, Coll Med, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 1, Dept Intens Care Med, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China
[3] Zhejiang Univ, Affiliated Hosp 1, Dept Lab Med, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China
[4] Key Lab Clin In Vitro Diagnost Tech Zhejiang Prov, Hangzhou 310003, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
SEPSIS; IMMUNOTHERAPY; DYSFUNCTION; CANCER;
D O I
10.1155/2018/1632902
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We aim to investigate the effects of Tim-3 and programmed cell death-1 (PD-1) on the monocytes and T lymphocytes in septic patients. Expression of Tim-3 and PD-1 on the CD3, CD4, and CD8 lymphocytes and monocytes was determined using flow cytometry. CBA technique was utilized to determine the expression of cytokines in the lymphocyte supernatant in addition to the IL-10 and TNF-alpha positivity in monocytes in the presence of Tim-3 and/or PD-1 receptor blockade. Compared with the normal control, significant elevation was observed in the expression of PD-1 on CD3 (P = 0 004), CD4, and CD8 monocytes. Blockade of the Tim-3 signaling pathway contributed to the significant elevation of IL-10 and TNF-alpha in the supernatant of T lymphocytes in the septic patients, while the PD-1 signaling pathway blockade only triggered the obvious elevation of TNF-alpha in the T lymphocytes. Blockade of Tim-3 and PD-1 induced the positivity of IL-10- and TNF-alpha-expressing cells in the peripheral monocytes. Significant changes were noticed in the Tim-3 and PD-1 in the T lymphocytes and monocytes. Blockade of Tim-3 and PD-1 contributed to the function of lymphocytes and monocytes. In the septic process, Tim-3 and PD-1 played crucial roles in the immune response of T lymphocytes and monocytes.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] CTLA-4, PD-1 and TIM-3 expression predominantly downregulated in MS patients
    Mohammadzadeh, Adel
    Rad, Isa Abdi
    Ahmadi-Salmasi, Babak
    JOURNAL OF NEUROIMMUNOLOGY, 2018, 323 : 105 - 108
  • [32] Triple checkpoint blockade targeting PD-1, TIM-3, and LAG-3 reinvigorates ovarian cancer-infiltrating T cells by increasing T cell polyfunctionality and effector function
    Kaufmann, Johanna K.
    Flynn, Brianna
    Morse, Kevin
    Speranza, Maria C.
    Zhou, Jing
    Ramaswamy, Sridhar
    Mackay, Sean
    Coleman, Kevin G.
    CANCER RESEARCH, 2019, 79 (13)
  • [33] Investigation of immune checkpoint molecules (CTLA-4, PD-1, PD-L1, Tim-3) expressions in preeclampsia: A comparative study of membranous and soluble forms
    Parhizkar, Forough
    Soltani-Zangbar, Mohammad Sadegh
    Shekari, Najibeh
    Hajiesmailpoor, Zanyar
    Parsania, Sara
    Aghebati-Maleki, Ali
    Aghebati-Maleki, Leili
    HUMAN IMMUNOLOGY, 2025, 86 (03)
  • [34] Immune checkpoint proteins PD-1 and TIM-3 are both highly expressed in liver tissues and correlate with their gene polymorphisms in patients with HBV-related hepatocellular carcinoma
    Li, Zhu
    Li, Na
    Li, Fang
    Zhou, Zhihua
    Sang, Jiao
    Chen, Yanping
    Han, Qunying
    Lv, Yi
    Liu, Zhengwen
    MEDICINE, 2016, 95 (52)
  • [35] Expression and function of PD-1 and TIM-3 in non-small cell lung cancer (NSCLC)
    Travers, Jonathan
    McEachern, Krtisten
    Ghosh, Srimoyee
    Ramaswamy, Sridhar
    Jenkins, David
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [36] TIM-3 and TIGIT are possible immune checkpoint targets in patients with bladder cancer
    Attalla, Kyrollis
    Farkas, Adam M.
    Anastos, Harry
    Audenet, Francois
    Galsky, Matthew D.
    Bhardwaj, Nina
    Sfakianos, John P.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (09) : 403 - 406
  • [37] TIM-3 AND TIGIT ARE POTENTIAL IMMUNE CHECKPOINT TARGETS IN PATIENTS WITH BLADDER CANCER
    Sfakianos, John
    Farkas, Adam
    Daza, Jorge
    Anastos, Harry
    Galsky, Matthew
    Bhardwaj, Nina
    JOURNAL OF UROLOGY, 2019, 201 (04): : E820 - E820
  • [38] PD-1 and Tim-3 Regulate the Expansion of Tumor Antigen-Specific CD8+ T Cells Induced by Melanoma Vaccines
    Fourcade, Julien
    Sun, Zhaojun
    Pagliano, Ornella
    Chauvin, Joe-Marc
    Sander, Cindy
    Janjic, Bratislav
    Tarhini, Ahmad A.
    Tawbi, Hussein A.
    Kirkwood, John M.
    Moschos, Stergios
    Wang, Hong
    Guillaume, Philippe
    Luescher, Immanuel F.
    Krieg, Arthur
    Anderson, Ana C.
    Kuchroo, Vijay K.
    Zarour, Hassane M.
    CANCER RESEARCH, 2014, 74 (04) : 1045 - 1055
  • [39] Serial changes in two immune checkpoint receptors and ligands, Tim-3/Gal-9 and PD-1/PD-L1 in peripheral blood prior to miscarriage: Comparison with pregnancies resulting in a live birth
    Zhang, Tao
    Zhao, Yiwei
    Cheung, Wing Ching
    Gan, Yong Huang
    Huang, Lin
    Li, Mingqing
    Leung, Kam Tong
    Chung, Piu Wah
    Wang, Chi Chiu
    Laird, Susan
    Chen, Xiaoyan
    Li, Tin Chiu
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2022, 87 (05)
  • [40] A bivalent Tim-3/PD-1 bispecific antibody for the treatment of PD-1 antibody resistant or refractory NSCLC.
    Liu, Jiajian
    Luan, Y.
    Deng, H.
    Wang, F.
    Wang, C.
    Zhang, Z.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)